Search by Drug Name or NDC

    NDC 29033-0037-30 Dapsone 100 mg/1 Details

    Dapsone 100 mg/1

    Dapsone is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Nostrum Laboratories, Inc.. The primary component is DAPSONE.

    Product Information

    NDC 29033-0037
    Product ID 29033-037_0052abbe-14fe-425d-b643-066cc17c0eab
    Associated GPIs 16300010000320
    GCN Sequence Number 009622
    GCN Sequence Number Description dapsone TABLET 100 MG ORAL
    HIC3 W4P
    HIC3 Description ANTILEPROTICS
    GCN 43360
    HICL Sequence Number 004177
    HICL Sequence Number Description DAPSONE
    Brand/Generic Generic
    Proprietary Name Dapsone
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dapsone
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 100
    Active Ingredient Units mg/1
    Substance Name DAPSONE
    Labeler Name Nostrum Laboratories, Inc.
    Pharmaceutical Class Sulfone [EPC], Sulfones [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203887
    Listing Certified Through 2024-12-31

    Package

    NDC 29033-0037-30 (29033003730)

    NDC Package Code 29033-037-30
    Billing NDC 29033003730
    Package 30 TABLET in 1 BOTTLE (29033-037-30)
    Marketing Start Date 2016-05-09
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.94242
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description DAPSONE 100 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis